SCHEMBL8766911

SCHEMBL8766911

CCC(C(=O)c1ccc(OCCCCl)cc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.61
HSD17B10 Q99714 1/20 0.61
SMN1; SMN2 Q16637 8/20 0.57
MAPT P10636 3/20 0.57
TP53 P04637 3/20 0.57
MEN1 O00255 1/20 0.57
THRB P10828 1/20 0.57
KMT2A Q03164 1/20 0.57
MITF O75030 2/20 0.56
RAB9A P51151 2/20 0.56
NLRP1 Q9C000 1/20 0.56
JAK2 O60674 2/20 0.54
PAX8 Q06710 1/20 0.49
ALDH1A1 P00352 3/20 0.49
GAA P10253 1/20 0.47
TSHR P16473 2/20 0.46
HPGD P15428 1/20 0.46
HIF1A Q16665 1/20 0.46
GBA1 P04062 1/20 0.46
PKM P14618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8767682 0.96 LMNA (0.59) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL8645421 0.95 LMNA (0.58) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL10828017 0.95 LMNA (0.58) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL8766893 0.95 LMNA (0.58) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL845072 0.95 LMNA (0.61) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL11500794 0.88 LMNA (0.62) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL7991466 0.86 LMNA (0.61) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL13531143 0.86 LMNA (0.61) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL8656435 0.86 LMNA (0.57) LMNAHSD17B10SMN1; SMN2MAPTTP53
SCHEMBL10827595 0.86 BCHE (0.59) LMNAHSD17B10SMN1; SMN2MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0638064-B1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECH GROUP (GB) 1997-08-13 EP disclosed
US-5589500-A TREATMENT OF TUMORS OR ANTICARCINOGENIC AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-12-31 US disclosed
WO-1993022275-A1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECHNOLOGY GROUP LTD (GB) 1993-11-11 WO disclosed